Hypaque-m,90% and Apraxia - a phase IV clinical study of FDA data
We study 1,718 people who take Hypaque-m,90% or have Apraxia. No report of Apraxia is found in people who take Hypaque-m,90%.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Hypaque-m,90%?
Hypaque-m,90% has active ingredients of diatrizoate meglumine; diatrizoate sodium.
What is Apraxia?
Apraxia (disorder that affects a person's ability to organize the movements of the muscles used in speech) is found to be associated with 1,010 drugs and 837 conditions by eHealthMe.
Do you take Hypaque-m,90% and have Apraxia?Check whether Apraxia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Apraxia and when was it recovered:
Expand to all the drugs that have ingredients of diatrizoate meglumine; diatrizoate sodium:
Alternative drugs to, pros and cons of Hypaque-m,90%:
Apraxia treatments and more:
- Apraxia (1,718 reports)
COVID vaccines that are related to Apraxia:
- Apraxia in Moderna COVID Vaccine
- Apraxia in Pfizer BioNTech Covid Vaccine
- Apraxia in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Apraxia:
All the conditions that are associated with Apraxia:
How the study uses the data?
The study uses data from the FDA. It is based on diatrizoate meglumine; diatrizoate sodium (the active ingredients of Hypaque-m,90%) and Hypaque-m,90% (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Piperacillin And Tazobactam and Yasmin drug interaction - 2 seconds ago
- Folic Acid and Anhedonia - 4 seconds ago
- Schizophrenia and Headache - 9 seconds ago
- Metformin and Stomatitis - 21 seconds ago
- Allegra and Fall - 29 seconds ago
- Zestril and Death - 34 seconds ago
- L-Aspartate and Furosemide drug interaction - 35 seconds ago
- Neutrophilia and drugs of ingredients of pregabalin - 37 seconds ago
- Pepcid and Endometrial Cancer - 42 seconds ago
- Human Chorionic Gonadotropin Abnormal and pfizer biontech covid vaccine - 52 seconds ago